Regenerative Medical Technology (RMTG) EBITDA Margin (2019 - 2026)
Regenerative Medical Technology's EBITDA Margin was 24.91% in Q2 2026, up 44.76 percentage points from -19.86% a year earlier but down 15.16 percentage points from the prior quarter.
Regenerative Medical Technology (RMTG) EBITDA Margin (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Regenerative Medical Technology's EBITDA Margin was 29.64% through Jun 30, 2026, up 18.84 percentage points year-over-year; for FY2025, it came in at 15.30%, down 43.82 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -2534.11 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 59.12% in FY2024 (-51.04 pp), 110.16% in FY2023 (+62.80 pp), 47.36% in FY2022 (+2099.20 pp) and -2051.84% in FY2021 (-4601.24 pp).
- Quarterly EBITDA Margin has moved between -5284.68% (Q3 2021) and 121.93% (Q1 2024) over five years.
- Compared with a year earlier, EBITDA Margin has increased for three straight quarters, with an average year-over-year change of -45.08 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2022 (a gain of 5369.91 percentage points); the worst was Q4 2021 (a drop of 19524.14 percentage points).
- Per Business Quant data, RMTG's EBITDA Margin in the three quarters before Q2 2026 was 40.06% (Q1 2026), 37.03% (Q4 2025) and 12.60% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Regenerative Medical Technology | 412,169.03 | -4.11 Mn | 2.58 Mn | 24.91% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.91% |
| Mar 31, 2026 | 40.06% |
| Dec 31, 2025 | 37.03% |
| Sep 30, 2025 | 12.60% |
| Jun 30, 2025 | -19.86% |
| Mar 31, 2025 | 13.69% |
| Dec 31, 2024 | 23.64% |
| Sep 30, 2024 | 17.70% |
| Jun 30, 2024 | 113.50% |
| Mar 31, 2024 | 121.93% |
| Dec 31, 2023 | 117.94% |
| Sep 30, 2023 | 121.87% |
| Jun 30, 2023 | 108.53% |
| Mar 31, 2023 | 95.19% |
| Dec 31, 2022 | 65.86% |
| Sep 30, 2022 | 85.23% |
| Jun 30, 2022 | 36.50% |
| Mar 31, 2022 | -23.53% |
| Dec 31, 2021 | -29.86% |
| Sep 30, 2021 | -5,284.68% |
Regenerative Medical Technology EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RMTG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RMTG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RMTG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();